Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.
about
Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta geneSilencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinomaIdentification of differentially expressed genes in spontaneously regressing melanoma using the MeLiM swine model.Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.Transcriptome profiling of the theca interna in transition from small to large antral ovarian folliclesTumor Suppressor RARRES1 Regulates DLG2, PP2A, VCP, EB1, and Ankrd26.Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential.G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells.Tazarotene-induced gene 1 inhibits prostaglandin E2-stimulated HCT116 colon cancer cell growth.Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding.Latexin is down-regulated in hematopoietic malignancies and restoration of expression inhibits lymphoma growth.DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage.DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients.Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycleCandidate markers that associate with chemotherapy resistance in breast cancer through the study on Taxotere-induced damage to tumor microenvironment and gene expression profiling of carcinoma-associated fibroblasts (CAFs).Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanomaSecretome survey of human plexiform neurofibroma derived Schwann Cells reveals a secreted form of the RARRES1 protein.Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma.Tazarotene-induced gene 2 is associated with poor survival in non-small cell lung cancer.Protein constituents of the eggshell: eggshell-specific matrix proteins.Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1Tazarotene-Induced Gene 1 Enhanced Cervical Cell Autophagy through Transmembrane Protein 192A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors.What makes an egg unique? Clues from evolutionary scenarios of egg-specific genes.The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice.Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling.RBM5-AS1 Is Critical for Self-Renewal of Colon Cancer Stem-like Cells.Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73.An in vivo RNAi screen identifies SALL1 as a tumor suppressor in human breast cancer with a role in CDH1 regulation.The hematopoietic stem cell regulatory gene latexin has tumor-suppressive properties in malignant melanoma.The SNP rs6441224 influences transcriptional activity and prognostically relevant hypermethylation of RARRES1 in prostate cancer.Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma.Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXN.Prognostic significance of osteopontin expression in human prostate cancer.Computing molecular signatures as optima of a bi-objective function: method and application to prediction in oncogenomics.DNA microarray analysis of vitamin D-induced gene expression in a human colon carcinoma cell line.Developmentally regulated SMAD2 and SMAD3 utilization directs activin signaling outcomes.Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma.Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness.
P2860
Q28235706-874A29BC-F993-4208-AD3E-1C269CF6871AQ28285236-54AC0866-D331-44AE-A52E-FFD96345C7B6Q33329652-F9F2F746-BBAD-4FB9-BCB7-76CCCAAD0318Q33603723-FA78DF59-E78F-45B7-8B24-6997D4D599D8Q33618252-F31F2571-007A-4459-A7DB-95331454D7F6Q33692936-3F3FC8DA-8EC9-4BFC-88E7-7FF0B9554B8FQ33863314-02235C4B-7F16-4E01-A7D9-BD1D922DDC10Q33901671-A4434C83-6061-448B-82F2-ED8B3B86F4C9Q34086015-DBF95C96-F277-497C-B110-573004D0E35EQ34277489-DA839509-C459-4B4E-86F3-B4BC2A174B30Q34427804-C30F48E0-F207-45F0-861E-2D8C9EC71E60Q34446604-A0056872-77DC-4505-B655-B3ABDE571686Q34447242-EC2D6B2F-A93B-49BD-8127-C7E70D6C715AQ34622583-67B6C0CC-3F6F-471B-8EFD-9F73860C672EQ34706189-A67FD535-6A0D-412C-AC06-AE1D7AE9A6C4Q34948192-7E52D0C7-A3FB-4282-8EF7-D44B228EFF15Q35091482-198E05E7-10C3-40F3-95E3-EA6CC734E1CBQ36197438-F79EB8A9-FB6E-449F-97B6-78E698CC6687Q36425752-640241E3-741B-4694-9589-7172CA9C2339Q37288283-6F413A54-7665-4D50-863C-733637597F9AQ37487657-BEB2058E-8452-4D58-B53A-04A43247BDAFQ37536796-2F985B76-149B-4EE1-A80A-2194267295FDQ37575776-1837C081-8E04-4965-B36F-559F791D3243Q37687723-093281ED-2F50-4E7D-A285-97DCB65A3A93Q37779429-9ABBAC36-419E-40B9-BEDD-DD4F1ED2214AQ38305833-E0573BA8-C9AD-46BE-9231-344814479115Q38323773-2AB9DED6-7F8C-4697-9771-073ACCCD05FBQ38752182-6F8E8C2C-F0D1-48A9-B5C3-3949A86E9862Q38884723-3D024DC5-DA09-4E05-B2B2-F8C29C0265EAQ39051606-8AD90BAE-4794-447E-9880-501544946D27Q39201926-0F9FEE69-5A62-4EB1-BCEE-A9BD6D2CEB14Q39351158-13096A20-3B8D-4ACE-AE74-352AF532760CQ39938055-70F89423-9550-4688-8675-0C7DF9170C9FQ40289727-E6841A09-84CE-4B44-982D-37899F6DAAABQ40343105-0A093BC2-A1AB-4B3D-A775-648EC0F94B8CQ40521338-A6909AF6-EBF8-442C-82F4-62C7F4D1C53FQ40582996-7616DB4C-4CD8-423C-9698-6342504D9E02Q42130956-7937E61F-9DE0-4522-A122-E75ED77786E4Q47110757-F993429C-B7C6-4CB8-8198-6CE8C1D82A59Q47831155-DD0166C2-8D5A-4733-B851-408F4B9AE357
P2860
Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tazarotene-induced gene 1 (TIG ...... elationship to tumorigenicity.
@ast
Tazarotene-induced gene 1 (TIG ...... elationship to tumorigenicity.
@en
Tazarotene-induced gene 1
@nl
type
label
Tazarotene-induced gene 1 (TIG ...... elationship to tumorigenicity.
@ast
Tazarotene-induced gene 1 (TIG ...... elationship to tumorigenicity.
@en
Tazarotene-induced gene 1
@nl
prefLabel
Tazarotene-induced gene 1 (TIG ...... elationship to tumorigenicity.
@ast
Tazarotene-induced gene 1 (TIG ...... elationship to tumorigenicity.
@en
Tazarotene-induced gene 1
@nl
P2093
P356
P1476
Tazarotene-induced gene 1 (TIG ...... elationship to tumorigenicity.
@en
P2093
Carol Beesley
Christopher S Foster
Manal Abd El-Ghany
Paul Smith
Philip S Rudland
Youqiang Ke
P304
P356
10.1093/JNCI/94.7.482
P407
P577
2002-04-01T00:00:00Z